Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02278783
Title Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Utah
Indications

ovary epithelial cancer

fallopian tube cancer

peritoneum cancer

Therapies

Regorafenib

Age Groups: adult
Covered Countries USA


No variant requirements are available.